| Centers | ||
| Drug Discovery Unit | VMCC, University of Michigan | FDA Oncology Center of Excellence Project Catalyst | 
| The Drug Discovery Unit (DDU) is a fully integrated drug discovery group established to translate world-class biology research into novel drug targets and candidate drugs. Housed within purpose built facilities at the University of Dundee, the  DDU...Read more | The VMCC is an on-campus core facility for the design and synthesis of drug-like molecules and diagnostic probes used in biomedical investigations. Our Mission: To assist biomedical researchers in translating novel therapeutic hypotheses into... | Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation | 
| Partnerships | Events | Jobs | 
| Sanofi and Stanford's Bio-X to Collaborate on Early Stage ResearchSanofi and Stanford University's Bio-X have entered into a multi-year collaboration that support interdisciplinary collaborative research to be conducted at Stanford. A joint steering committee comprising of representatives from Stanford and... View all Argenta and ANTABIO Announce Drug Discovery CollaborationArgenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration partner Antabio in an anti-bacterial drug... View all Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial DrugsBroad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for... View all | No EVENTS for listing | No Job Posts | 



 
								 
								 
								 
						 		
								 
								
								 
								
								 
								
								 
								
								 
								
								 
								
								